Serum levels of tumor necrosis factor (TNF) and interleukin(IL-1) were
studied in 20 HSP patients, in the acute phase and after remission, b
y ELISA technique. Skin biopsies obtained during the acute phase both
from a lesion and from unaffected skin, as well as during remission, w
ere immunostained for TNF, IL-1, and IL-6. The mean age of the patient
s was 9.8 (5-13). Mean serum TNF levels during the acute phase and rem
ission were 14.0 +/- 8.9 pg/ml, and 6.8 +/- 2.4 pg/ml, respectively (p
<0.05). Serum TNF levels in patients with renal involvement (18.8 +/-
10.2 pg/ml) were significantly higher than in those without (10.8 +/-
6.5 pg/ml) (p<0.05). Serum levels of IL-1 in the acute phase and remis
sion were undetectable. All specimens showed leukocytoclastic vasculit
is. Immunohistochemical studies revealed TNF, and a less intense IL-1
and IL-6 staining in the nucleated epidermal layer, with a granular, i
ntracellular pattern. Staining was significantly increased in the affe
cted skin during the acute phase. These results suggest that TNF, IL-1
, and IL-6 may play a role as a mediator of inflammation in HSP.